Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q4 2014 (← Previous) (Next →)

Filing Date: Feb 17, 2015

Total Value ($000): $254,119 (100.0% shares, 0.0% debt)

Holdings (14)

— Medivation, Inc. 87.2%

Value ($000) $221,584 Shares 2,244,519 Est. Cost $49.20 Unrealized —

— Ampio Pharmaceuticals Inc. 4.6%

Value ($000) $11,622 Shares 3,388,322 Est. Cost $6.03 Unrealized —

— Synthetic Biologics Inc. 2.0%

Value ($000) $4,965 Shares 3,400,816 Est. Cost $1.48 Unrealized —

— Alcobra Ltd 1.3%

Value ($000) $3,228 Shares 865,315 Est. Cost $7.50 Unrealized —

— Newlink Genetics Corp 1.2%

Value ($000) $3,078 Shares 77,437 Est. Cost $19.35 Unrealized —

— Keryx Biopharmaceuticals Inc. 1.1%

Value ($000) $2,830 Shares 200,000 Est. Cost $10.21 Unrealized —

— Bio Blast Pharma Ltd 0.9%

Value ($000) $2,161 Shares 338,110 Est. Cost $7.27 Unrealized —

— Advaxis Inc. 0.7%

Value ($000) $1,802 Shares 225,000 Est. Cost $8.01 Unrealized —

— Auspex Pharmaceuticals Inc. 0.4%

Value ($000) $1,050 Shares 20,000 Est. Cost $52.50 Unrealized —

— Inovio Pharmaceuticals Inc. 0.3%

Value ($000) $754 Shares 82,088 Est. Cost $10.86 Unrealized —

— Advaxis Inc. 0.2%

Value ($000) $467 Shares 112,500 Est. Cost $4.15 Unrealized —

— Galmed Pharmaceuticals Ltd 0.1%

Value ($000) $377 Shares 65,000 Est. Cost $11.48 Unrealized —

PVCT Provectus Biopharmaceuticals 0.1%

Value ($000) $160 Shares 200,000 Est. Cost $1.90 Unrealized -51.8%

— Nephrogenex Inc 0.0%

Value ($000) $41 Shares 3,072 Est. Cost $8.24 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Medivation, Inc.	2,244,519	$221,584	87.2%	$49.20	—	COM	58501N101
—	Ampio Pharmaceuticals Inc.	3,388,322	$11,622	4.6%	$6.03	—	COM	03209T109
—	Synthetic Biologics Inc.	3,400,816	$4,965	2.0%	$1.48	—	COM	87164U102
—	Alcobra Ltd	865,315	$3,228	1.3%	$7.50	—	SHS	M2239P109
—	Newlink Genetics Corp	77,437	$3,078	1.2%	$19.35	—	COM	651511107
—	Keryx Biopharmaceuticals Inc.	200,000	$2,830	1.1%	$10.21	—	COM	492515101
—	Bio Blast Pharma Ltd	338,110	$2,161	0.9%	$7.27	—	SHS	M20156101
—	Advaxis Inc.	225,000	$1,802	0.7%	$8.01	—	COM NEW	7624208
—	Auspex Pharmaceuticals Inc.	20,000	$1,050	0.4%	$52.50	—	COM	05211J102
—	Inovio Pharmaceuticals Inc.	82,088	$754	0.3%	$10.86	—	COM NEW	45773H201
—	Advaxis Inc.	112,500	$467	0.2%	$4.15	—	W EXP 07/15/201	7624117
—	Galmed Pharmaceuticals Ltd	65,000	$377	0.1%	$11.48	—	SHS	M47238106
PVCT	Provectus Biopharmaceuticals	200,000	$160	0.1%	$1.90	-51.8%	COM	74373P108
—	Nephrogenex Inc	3,072	$41	0.0%	$8.24	—	COM	640667101